Trials / Conditions / Recurrent Intrahepatic Cholangiocarcinoma
Recurrent Intrahepatic Cholangiocarcinoma
3 registered clinical trials studyying Recurrent Intrahepatic Cholangiocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A Co NCT05564403 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or With NCT04941287 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder C NCT03257761 | University of Southern California | Phase 1 |